Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
CAPS Rating:
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Cramer's best stock to own for 2012